Not available
Quote | Immutep Limited (NASDAQ:IMMP)
Last: | $1.942 |
---|---|
Change Percent: | 0.1% |
Open: | $1.91 |
Close: | $1.94 |
High: | $1.99 |
Low: | $1.91 |
Volume: | 66,087 |
Last Trade Date Time: | 07/19/2024 03:00:00 am |
News | Immutep Limited (NASDAQ:IMMP)
Media Release Study expected to enrol first participants during Q3 CY2024 SYDNEY, AUSTRALIA, July 17, 2024 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a clinical-stage biotechnology company developing no...
2024-07-15 13:54:02 ET Summary Immutep Limited achieved positive results in the phase 2b study, using efti + Keytruda for the treatment of patients with 1st-line head and neck squamous cell carcinoma; Both PD-L1 positive and negative patients. Company to meet with FDA to be in a p...
Message Board Posts | Immutep Limited (NASDAQ:IMMP)
Subject | By | Source | When |
---|---|---|---|
MomentumIts trading | make it happen | investorshub | 05/15/2023 2:39:54 AM |
short squeeze article | make it happen | investorshub | 05/14/2023 9:17:55 PM |
$IMMP The gaining | everything | investorshub | 05/12/2023 7:52:42 AM |
Price gaining last trade up | stocks2watch | investorshub | 05/09/2023 1:11:31 PM |
$IMMP bulls and bears | calahan67 | investorshub | 04/28/2023 1:37:20 PM |
News, Short Squeeze, Breakout and More Instantly...
Media Release Study expected to enrol first participants during Q3 CY2024 SYDNEY, AUSTRALIA, July 17, 2024 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) ("Immutep” or “the Company”), a clinical-stage biotechnology company developing no...
2024-07-12 10:45:04 ET QuantumScape Corp (QS) QS is trading UP for the last 5 days, and it at trading at $7.84 with volume of 22,322,158 and a one day change of $0.78 (10.98%). QuantumScape Corp has a 52-week low of 4.67 and a 52-week high of $13.86. The business's 50-day moving ave...
Media Release Efti in combination with KEYTRUDA® (pembrolizumab) achieved a 35.5% response rate in evaluable patients (N=31), according to RECIST 1.1, among the highest recorded for a treatment approach not containing chemotherapy in patients with CPS <1 High complete response...